Dynamic Entropy Technology, founded in 2018 and headquartered in Pasco, Washington, is a medical device manufacturer dedicated to advancing health sciences. The company's core mission is to innovate and improve medical technologies, focusing on areas such as cancer treatment, vaccine development, antimicrobials, biomaterials, and infectious diseases. Their product offerings include wound-healing collagen dressings (trademarked as Collagenized Dressings™), vaccine formulations, drug delivery systems, and biomass and biochemicals, including biofuels.
Notable figures affiliated with Dynamic Entropy Technology include CEO Dr. Mark, who leads the company's strategic direction. The company has achieved significant milestones in contract research and development services, particularly in biomineralization process development. Their innovations have made a substantial impact on the medical device industry by providing advanced solutions for complex health challenges, thereby improving patient outcomes and contributing to the broader field of health sciences.